top of page

INNOVATING AESTHETIC AND MEDICAL SOLUTIONS

WHO WE ARE

Imperial Bioscience is a biopharmaceutical company committed to developing and commercialising innovative therapeutics to provide life-enhancing treatments. Traditional methods of delivering drug substances (active ingredients) into the human body include orally administered medicines, injections, ointments, and patches. The "dissolving microstructure"; developed, produced, and commercialised by Imperial Bioscience has enhanced the existing drug delivery system, making it not only safer and more convenient but also more efficient in the delivery of active ingredients.

 

The new delivery system developed by Imperial Bioscience leads to significant change and enhances convenience in people's daily lives. It also helps many people maintain their youth and beauty by delivering active ingredients more effectively than conventional cosmetics as well as more safely and conveniently than hospital procedures and treatments.

OUR TECHNOLOGY

c6img.png

Hydrocolloid base


This water-resistant backing sticks 
firmly to the target area, making sure that the patch stays securely in place.

Self-dissolving micro-cones


Ingredients-filled microstructures
are gently dissolved within
two hours of application.

Our products are based on natural hyaluronic acid in the form of self-dissolving micro-cones. The microstructure concentrates and precisely delivers the active ingredients to target areas of concern for the improvement of the targeted skin condition.

WHY IT WORKS

The innovative microstructure overcomes the skin diffusion limitations for optimum results that raise the bar for performance and safety.

c7img_edited.png

INFILTRATES

Pain-free micro-cones

permeate the

(stratum corneum)

the skin's top layer

c7img.png

DISSOLVES

Micro-cones dissolve

within two hours and

start releasing active

ingredients.

c7img_edited.png

DELIVERS

Active ingredients are

delivered directly and

deeply into the skin for

effective treatments.

A dissolving microneedle patch is a method that delivers drugs effectively by penetrating the skin with a structure as thin as a mosquito's proboscis. This microneedle patch represents a novel drug delivery system, often referred to as a patch-type painless injection, merging the simplicity of a patch with the efficient drug delivery of an injection

OUR PARTNERS

LATEST NEWS

Get the latest updates from Imperial Bioscience on new research, company news and events

"The Best Beauty And Skincare Product To Invest In 2022"

forbes-white-logo.png
M81A3333.jpg
Dr. MUHAMMET AVCIL
Chief Executive Officer

Dr Muhammet Avcil, the CEO of Imperial Bioscience Ltd, stands as a visionary leader at the forefront of scientific innovation in the pharmaceutical industry. With a background in biotechnology and extensive expertise in drug-delivery technologies, Dr Avcil is a globally recognized biomedical scientist and one of the foremost experts in drug delivery. He has played a pivotal role in shaping the company's journey towards revolutionizing healthcare. His unwavering commitment to pushing the boundaries of what's possible, coupled with a passion for research and development, has led Imperial Bioscience to create cutting-edge Microarray Patch (MAP) technology.

 

Dr Avcil's leadership, combined with his multi award-winning achievements, has not only driven the company's success but has also contributed significantly to advancements in patient-centric solutions. Under his guidance, Imperial Bioscience continues to make remarkable strides in transforming drug delivery methods for improved patient outcomes.

OUR ABSTRACTS & PUBLICATIONS

Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study

MAY 28 2019

 

Aging skin is a gradual physiological process associated with functional and structural changes of the skin. 

 

Clinical efficacy of dissolvable microneedles armEd with anti-melanogenic compounds to counter hyperpigmentation

JULY 21 2020

 

Hyperpigmentation is a complex physiological process associated with alterations in skin colour due to melanin overproduction and distribution.

Microneedles in Drug Delivery:

Progress and Challenges

OCTOBER 28 2021

In recent years, an innovative transdermal delivery technology has attracted great interest for its ability to distribute therapeutics and cosmeceuticals for several applications, including vaccines, drugs, and biomolecules for skin-related problems.

bottom of page